Idebenone 150 MG Oral Tablet
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
15
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Leber's Hereditary Optic Neuropathy
Conditions
Leber's Hereditary Optic Neuropathy
Trial Timeline
— → —
NCT ID
NCT04381091About Idebenone 150 MG Oral Tablet
Idebenone 150 MG Oral Tablet is a pre-clinical stage product being developed by Santhera Pharmaceuticals for Leber's Hereditary Optic Neuropathy. The current trial status is completed. This product is registered under clinical trial identifier NCT04381091. Target conditions include Leber's Hereditary Optic Neuropathy.
Hype Score Breakdown
Clinical
5
Activity
2
Company
2
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04381091 | Pre-clinical | Completed |
Competing Products
4 competing products in Leber's Hereditary Optic Neuropathy
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Idebenone + Placebo | Santhera Pharmaceuticals | Phase 2 | 44 |
| Idebenone | Santhera Pharmaceuticals | Approved | 77 |
| Idebenone | Santhera Pharmaceuticals | Pre-clinical | 15 |
| Idebenone + Placebo | Santhera Pharmaceuticals | Phase 3 | 69 |